Vimarsana
Biggest News Aggregation in the World

Page 13 - Iontech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iontech Today - Breaking & Trending Today

BioNTech : AGM Speech of CEO | MarketScreener - Vimarsana News

BioNTech : AGM Speech of CEO | MarketScreener

Annual General Meeting BioNTech SE May 25, 2023 English Convenience Translation: German is the official language. ... | May 25, 2023

OPINION: There's fresh hope on one of the toughest cancers to cure - Vimarsana News

OPINION: There's fresh hope on one of the toughest cancers to cure

The caveats to these studies are many. But there is finally real hope that the bleak survival statistics for pancreatic cancer could meaningfully change.

Source: adn.com
A New Pancreatic Cancer Vaccine Personalized to Each Patient - Vimarsana News

A New Pancreatic Cancer Vaccine Personalized to Each Patient

A new pancreatic cancer vaccine shows promise. In a small trial, treatment worked by using individual patients' mRNA to create a custom vaccine.

BioNTech 1Q Earnings, Revenue Drop on Waning Covid-19 Shot Sales - Vimarsana News

BioNTech 1Q Earnings, Revenue Drop on Waning Covid-19 Shot Sales

By Cecilia Butini BioNTech said Monday that earnings and revenue declined significantly in the first quarter of the year as it booked lower sales of its best-selling Covid-19 vaccine compared... | May 8, 2023

BioNTech Q1 Net Profit Declines; Reiterates 2023 COVID-19 Vaccine Revenue Guidance - Vimarsana News

BioNTech Q1 Net Profit Declines; Reiterates 2023 COVID-19 Vaccine Revenue Guidance

BioNTech SE (BNTX) said its financial performance has been fully in line with the company's expectations for the first quarter of 2023. Commercial revenues decreased due to lower demand for COVID-19 vaccine.

Related Topics:
Ugur Sahin